Neuropeptide growth factors and cancer.
Woll
P J
PJ
CRC Department of Medical Oncology, Christie Hospital, Manchester, UK.
D000818:Animals; D019886:Gastrin-Releasing Peptide; D005755:Gastrins / Q000502:physiology; D006133:Growth Substances / Q000502:physiology*; D006801:Humans; D007705:Kinins / Q000502:physiology; D009369:Neoplasms / Q000473:pathology*; D009479:Neuropeptides / Q000502:physiology*; D009496:Neurotensin / Q000502:physiology; D010455:Peptides / Q000502:physiology; D014660:Vasoactive Intestinal Peptide / Q000502:physiology; D014667:Vasopressins / Q000502:physiology
D005755:Gastrins; D006133:Growth Substances; D007705:Kinins; D009479:Neuropeptides; D010455:Peptides; D014667:Vasopressins; D014660:Vasoactive Intestinal Peptide; D009496:Neurotensin; D019886:Gastrin-Releasing Peptide